NorthWest Biotherapeutics Inc (NWBO)

[Umibe5690]

With firm validation from a successful TLD result, BP will not discount the promise and value of direct. Again, my point is that LP knows what she has and has a "cannot refuse" valuation in mind. She is not going to sell out cheap. She may think the value is $50B while big P may think it less than $10B at the present time. Even if TLD is stellar, there may still be a large valuation disparity.

My bottom line point is that I am quite certain BP understands the potential of the DCVAX platform. It is not that they have ignored it. It is rather that the sticker price is too high. I think we both agree that it is more of an issue of valuation rather than a disinterest in the platform.